Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanotechnology, biomolecules and light unite to 'cook' cancer cells

Abstract:
Researchers are testing a new way to kill cancer cells selectively by attaching cancer-seeking antibodies to tiny carbon tubes that heat up when exposed to near-infrared light.

Nanotechnology, biomolecules and light unite to 'cook' cancer cells

Dallas, TX | Posted on June 16th, 2008

Biomedical scientists at UT Southwestern Medical Center and nanotechnology experts from UT Dallas describe their experiments in a study available online and in an upcoming print issue of Proceedings of the National Academy of Sciences.

Scientists are able to use biological molecules called monoclonal antibodies that bind to cancer cells. Monoclonal antibodies can work alone or can be attached to powerful anti-cancer drugs, radionuclides or toxins to deliver a deadly payload to cancer cells.

In this study, the researchers used monoclonal antibodies that targeted specific sites on lymphoma cells to coat tiny structures called carbon nanotubes. Carbon nanotubes are very small cylinders of graphite carbon that heat up when exposed to near-infrared light. This type of light, invisible to the human eye, is used in TV remote controls to switch channels and is detected by night-vision goggles. Near-infrared light can penetrate human tissue up to about 1 inches.

In cultures of cancerous lymphoma cells, the antibody-coated nanotubes attached to the cells' surfaces. When the targeted cells were then exposed to near-infrared light, the nanotubes heated up, generating enough heat to essentially "cook" the cells and kill them. Nanotubes coated with an unrelated antibody neither bound to nor killed the tumor cells.

"Using near-infrared light for the induction of hyperthermia is particularly attractive because living tissues do not strongly absorb radiation in this range," said Dr. Ellen Vitetta, director of the Cancer Immunobiology Center at UT Southwestern and senior author of the study. "Once the carbon nanotubes have bound to the tumor cells, an external source of near-infrared light can be used to safely penetrate normal tissues and kill the tumor cells.

"Demonstrating this specific killing was the objective of this study. We have worked with targeted therapies for many years, and even when this degree of specificity can be demonstrated in a laboratory dish, there are many hurdles to translating these new therapies into clinical studies. We're just beginning to test this in mice, and although there is no guarantee it will work, we are optimistic."

The use of carbon nanotubes to destroy cancer cells with heat is being explored by several research groups, but the new study is the first to show that both the antibody and the carbon nanotubes retained their physical properties and their functional abilities - binding to and killing only the targeted cells. This was true even when the antibody-nanotube complex was placed in a setting designed to mimic conditions inside the human body.

Biomedical applications of nanoparticles are increasingly attracting the attention of basic and clinical scientists. There are, however, challenges to successfully developing nanomedical reagents. One is the potential that a new nanomaterial may damage healthy cells and organisms. This requires that the effects of nanomedical reagents on cells and organisms be thoroughly studied to determine whether the reagents are inherently toxic.

"There are rational approaches to detecting and minimizing the potential for nonspecific toxicity of the nanoparticles developed in our studies," said Dr. Rockford Draper, leader of the team from UT Dallas and a professor of molecular and cell biology.

Other researchers from UT Southwestern involved in the research were lead authors Pavitra Chakravarty, a graduate student in biomedical engineering, and Dr. Radu Marches, assistant professor in the Cancer Immunobiology Center. Authors from UT Dallas' Alan G. MacDiarmid NanoTech Institute were Dr. Inga Musselman, Dr. Paul Pantano and graduate student Pooja Bajaj. Two undergraduate students in UT Southwestern's Summer Undergraduate Research Fellowship program - Austin Swafford from UT Dallas and Neil Zimmerman from the Massachusetts Institute of Technology - also participated.

The research was supported by the Cancer Immunobiology Center at UT Southwestern, the Robert A. Welch Foundation, the Department of Defense and the Center for Applied Biology at UT Dallas.

Dr. Vitetta is a co-inventor on a patent describing the techniques outlined in the study.

Visit www.utsouthwestern.org/cancercenter to learn more about UT Southwestern's clinical services in cancer.

####

For more information, please click here

Contacts:
Amanda Siegfried

214-648-3404

Copyright © UT Southwestern Medical Center

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Dr. Ellen Vitetta

Related News Press

News and information

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Nanomedicine

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Amino-functionalized carbon nanotubes act as a carrier for nerve growth factor April 21st, 2014

Discoveries

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Announcements

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014

Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE